Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 12
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| tablet, delayed release | 3 |
| Route | NDCs |
|---|---|
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| alpha cognition, inc. | 3 |
Exclusivity
Patents and exclusivities
12| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9763953 | ZUNVEYLbenzgalantamine gluconate | use | Dec 2026 |
| 11795176 | ZUNVEYLbenzgalantamine gluconate | substance | Jan 2042 |
| 12208167 | ZUNVEYLbenzgalantamine gluconate | product | Feb 2044 |
| 12551491 | ZUNVEYLbenzgalantamine gluconate | use | Jul 2045 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ZUNVEYL | benzgalantamine | tablet, delayed release, oral | 84054-005NDA |
| ZUNVEYL | benzgalantamine | tablet, delayed release, oral | 84054-010NDA |
| ZUNVEYL | benzgalantamine | tablet, delayed release, oral | 84054-015NDA |
Enquiry
Common questions
- Is Alpha Cognition, Inc. FDA approved?
- Alpha Cognition, Inc. holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Alpha Cognition, Inc. make?
- 3 products are listed under Alpha Cognition, Inc. in the openFDA NDC Directory, most often as tablet, delayed release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.